Wound healing is a sequence of complex events, an imbalance of which can result in a failure of the wound to heal, with significant implications for patients and health care services alike. Although the exact mechanism that underlies these events is not fully understood, inflammatory processes and the innate immune system play a vital role, not only in normal wound healing but also in the pathophysiology of delayed wound healing. These defense mechanisms are affected by underlying disease states and medical conditions, for example, diabetes, venous insufficiency, and the inflammation associated with acute trauma. Importantly, however, these processes are also modulated in health by bacteria within the wound. This article examines the role of the mediators of inflammation involved in the wound-healing process and discusses the function of these mediators when normal healing fails. The reaction of the wound to bacterial contamination and the effect of bacteria on wound healing are also discussed.
Nathan C. Points of control in inflammation. Nature2002;420:846-852.
2.
Moseley R, Stewart JE, Stephens P, et al. Extracellular matrix metabolites as potential biomarkers of disease activity in wound fluid: lessons learned from other inflammatory diseases. Br J Dermatol2004;150:401-413.
3.
Merkkes JR, Loots MAM, Van Der Wal AC, et al. Causes, investigation and treatment of leg ulceration. Br J Dermatol2003;148:388-401.
4.
Loots MA, Lamme EN, Zeegelaar J, et al. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. Trends Biochem2001;111:1027-1035.
5.
Mendez MV, Stanley A, Phillips T, et al. Fibroblasts cultured from distal lower extremities in patients with venous reflux display cellular characteristics of senescence. J Vasc Surg1998;28:1040-1050.
6.
Hammad LF. A study of the mechanical and microcirculatory properties of skin subject to venous ulceration, PhD thesis, University of Southampton, 2000.
7.
Stvrtinova V, Jahnova E, Weissova S, et al. Inflammatory mechanisms involving neutrophils in chronic venous insufficiency of lower limbs. Bratisl Lek Listy2001;102:235-239.
8.
Smith PD. Neutrophil activation and mediators of inflammation in chronic venous insufficiency. J Vasc Res1999;36(Suppl 1):24-36.
9.
Falanga V, Eaglestein WH. The “trap” hypothesis of venous ulceration. Lancet1993;341:1006-1008.
10.
Ågren MS, Eaglstein WH, Ferguson MW, et al. Causes and effects of the chronic inflammation in venous leg ulcers. Acta Derm Venereol (Stockh)2000;210:3-17.
11.
Pappas PJ, Falleck SR, Garcia A, et al. Role of leukocyte activation in patients with venous stasis ulcers. J Surg Res1995;59:553-559.
12.
Powell CC, Rohrer MJ, Barnard MR, et al. Chronic venous insufficiency is associated with increased platelet and monocyte activation and aggregation. J Vasc Surg1999;30:844-851.
13.
Lerman OZ, Galiano RD, Armour A, et al. Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol2003;162:303-312.
14.
Pierce GF. Inflammation in nonhealing diabetic wounds: the space time continuum does matter. Am J Pathol2001;159:399-403.
15.
Pitre DA, Seifert JlL, Bauer JA. Perineurium inflammation and altered connexin isoform expression in a rat model of diabetes related peripheral neuropathy. Neurosci Lett2001;303:67-71.
16.
Kelkar P, Masood M, Parry GJ. Distinctive pathological findings in proximal diabetic neuropathy (diabetic amyotrophy). Neurology2000;55:83-88.
17.
Walmsley D, Wiles PG. Myogenic microvascular responses are impaired in long-duration type 1 diabetes. Diabet Med1990;7:222-227.
18.
Boyko EJ, Ahroni JH, Smith DG, Davignon D. Increased mortality associated with diabetic foot ulcer. Diabet Med1996;13:967-972.
19.
Brown DL, Kao WW, Greenhalgh DG. Apoptosis down-regulates inflammation under the advancing epithelial wound edge: delayed patterns in diabetes and improvement with topical growth factors. Surgery1997;121:372-380.
20.
Jünger M, Steins A, Hahn M, et al. Microcirculatory dysfunction in chronic venous insufficiency (CVI). Microcirculation2000;7:s3-s12.
21.
Stephens P, Wall IB, Wilson MJ, et al. Anaerobic cocci populating the deep tissues of chronic wounds impair cellular wound healing responses in vitro. Br J Dermatol2003;148:456-466.
22.
Laato M, Ninikoski J, Lundberg C, et al. Inflammatory reaction and blood flow in experimental wounds inoculated with Staphylococcus aureus. Eur Surg Res1998;20:33-38.
23.
Smith PD. Update on chronic-venous-insufficiency-induced inflammatory processes. Angiology2000;52(Suppl 1):S35-S42.
24.
Edwards RE, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis2004;17:91-96.
25.
Wall IB, Davies CE, Hill KE, et al. Potential role of anaerobic cocci in impaired human wound healing. Wound Repair Regen2002;10:346-353.
26.
Cutting KF, Harding KG. Criteria to identify wound infection. J Wound Care1994;3:198-201.
27.
Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systemic approach to wound management. Wound Repair Regen2003;11(Suppl 1):S1-S28.
28.
Davies CE, Wilson MJ, Hill KE, et al. The use of molecular techniques to study microbial diversity in the skin: chronic wounds reevaluated. Wound Repair Regen2001;9:332-340.
29.
Dow G, Browne A, Sibbald RG. Infection in chronic wounds: controversies in diagnosis and treatment. Ostomy Wound Manage1999;45:23-40.
30.
Elek SD. Experimental staphylococcal infections in the skin of man. Ann N Y Acad Sci1956;65:85-90.
31.
Allen HE, Edgerton MT, Rodeheaver GT, et al. Skin dressings in the treatment of contaminated wounds. Am J Surg1973;126:45-48.
32.
Sapico F, Canawati H, Witte J, et al. Quantitative aerobic and anaerobic bacteriology of infected diabetic feet. J Clin Microbiol1980;12:413-420.
33.
Mertz PM. Cutaneous biofilms: friend or foe?Wounds2003;15:129-132.
34.
Serralta VW, Harrison-Balestra C, Cazzagnia AL, et al. Lifestyles of bacteria in wounds: presence of biofilms?Wounds2001;13:29-34.
35.
Konturek PC, Bzozowski T, Konturek SJ, et al. Influence of bacterial lipopolysaccharide on healing of chronic experimental ulcer in rat. Scand J Gastroenterol2001;36:1239-1247.
36.
Power C, Wang JH, Sookai S, et al. Bacterial wall products induce down regulation of vascular endothelial growth factor receptors on endothelial cells via a CD14-dependant mechanism: implications for surgical wound healing. J Surg Res2001;101:138-145.
37.
Tarnuzzer RW, Schultz GS. Biochemical analysis of acute and chronic wound environments. Wound Repair Regen1996;4:321-325.
38.
Nickoloff BJ. Cutaneous dendritic cells in the crossfire between innate and adaptive immunity. J Dermatol Sci2002;29:159-165.
39.
Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal2001;13:85-94.
40.
Mayer-Scholl A, Averhof P, Zychlinsky A. How do microbes and pathogens interact?Curr Opin Microbiol2004;7:62-66.
41.
Park JE, Barbul A. Understanding the role of immune regulation in wound healing. Am J Surg2004;187:11S-16S.
42.
Medzhitov R. Toll-like receptors and innate immunity. Nature Rev Immunol2001;1:135-145.
43.
Takeda K, Akira S. Roles of Toll-like receptors in innate immune responses. Genes Cells2001;6:733-742.
44.
Sabroe I, Read RC, Whyte MKB, et al. Toll-like receptors in health and disease: complex questions remain. J Immunol2003;171:1630-1635.
45.
Pukstadt BS, Ryan L, Thomas DW. An investigation of Toll-like receptor interaction with bacteria in the pathogenesis of chronic leg ulcers. 2nd World Union of Wound Healing Societies’ Meeting, July 8- July 13, 2004.
